Atlas Trials

Study of Cavosonstat (N91115) in Patients With CF Homozygous for the F508del-CFTR Mutation

Clinical trial NCT02589236 · COMPLETED

Trial details

NCT number
NCT02589236
Sponsor
Nivalis Therapeutics, Inc.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Cystic Fibrosis
Start date
2015-11-01
Primary completion
2016-12-01
Enrollment
138

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.